ActinoPharma Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Out of Business

  • Employees
  • 1

Employees

  • Latest Deal Type
  • Out of Business

ActinoPharma General Information

Description

Provider of inflammatory disease treatment services intended to serve patients. The company's services use heat-killed bacteria for the treatment of chronic inflammatory diseases, enabling medical professionals to provide immune-modulating effects for both humans and animals.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 26 Grosvenor Street
  • Mayfair
  • London W1K 4QW
  • England, United Kingdom
Primary Industry
Biotechnology
Other Industries
Other Healthcare Services
Drug Discovery
Vertical(s)
HealthTech, Life Sciences
Corporate Office
  • 26 Grosvenor Street
  • Mayfair
  • London W1K 4QW
  • England, United Kingdom

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ActinoPharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Out of Business 13-Feb-2024 Completed Out of Business
4. Secondary Transaction - Private 01-Feb-2021 Completed Generating Revenue
3. Early Stage VC 07-Mar-2013 Completed Generating Revenue
2. Early Stage VC 10-Jul-2012 $632K $1.97M Completed Startup
1. Early Stage VC 29-Dec-2011 $1.34M $1.34M Completed Startup
To view ActinoPharma’s complete valuation and funding history, request access »

ActinoPharma Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Pref 2
Pref 1
Pref 540,558 $0.001534 $3.07 $3.07 1x $3.07 28.72%
Ordinary 92,500 $0.001534 $3.07 $3.07 1x $3.07 4.92%
To view ActinoPharma’s complete cap table history, request access »

ActinoPharma Patents

  • 1

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • Pending

  • Expiring in next 12 mo

ActinoPharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-201102716-D0 Immunomodulators and heat shock proteins Inactive 16-Feb-2011

ActinoPharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ready to get started?

Request a free trial

ActinoPharma FAQs

  • When was ActinoPharma founded?

    ActinoPharma was founded in 2010.

  • Where is ActinoPharma headquartered?

    ActinoPharma is headquartered in London, United Kingdom.

  • What is the size of ActinoPharma?

    ActinoPharma has 1 total employees.

  • What industry is ActinoPharma in?

    ActinoPharma’s primary industry is Biotechnology.

  • Is ActinoPharma a private or public company?

    ActinoPharma is a Private company.

  • What is ActinoPharma’s current revenue?

    The current revenue for ActinoPharma is .

  • How much funding has ActinoPharma raised over time?

    ActinoPharma has raised $3.11M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process